Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
This study has been terminated.
(Based on preliminary parent study results)
Sponsor:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00550420
First received: October 25, 2007
Last updated: April 12, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | February 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | March 29, 2010 |